Awardee OrganizationHEBREW REHABILITATION CENTER FOR AGED
Description
Abstract Text
DESCRIPTION (provided by applicant): The Framingham Osteoporosis Study (FOS) is a prospective study that is part of the Framingham Heart Study, one of the longest running cohort studies in the world. FOS involves participants from the Original Cohort (1948-present) and the Offspring Cohort (2nd generation and spouses). Both cohorts have comprehensive data about osteoporosis risk factors, as well as having stored DNA, relevant genotyping being performed by other groups, and large numbers of extended families in whom a genome wide scan has been carried out. We propose to continue the FOS. Our preliminary findings suggest that patterns of food consumption, dietary silicon and phosphoric acid intake have influences on bone mineral density (BMD). We will study these dietary factors as they relate to changes in BMD and fractures in both Cohorts. Findings from these studies may offer potential dietary approaches to preventing osteoporosis. We have recently completed a genome wide scan on some of the extended families in FOS who have completed BMD and quantitative calcaneal ultrasound (QUS), and found several loci with suggestive linkage. In some cases, loci differed between the BMD and QUS phenotypes. The results of this linkage analysis will be used to suggest potential gene candidates for association studies in addition to the ones that we will investigate in this project: interleukin-6 (IL-6), transforming growth factor beta (TGF-Beta), and estrogen receptors alpha and beta (ERa and ERBeta). We recently discovered that women with bone loss or low BMD have greater severity of vascular calcification, suggesting that the two processes may have a common etiology. We will test the hypothesis that this common etiology is related to estrogen and the estrogen receptors by using electron beam computed tomography to quantify vascular calcification, by measuring serum estradiol and sex-hormone binding globulin, and by genotyping women for ERa and ERBeta. This will advance our understanding of two of the most common chronic diseases affecting older persons.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
bone density bone fracture bone metabolism clinical research diet disease /disorder proneness /risk estradiol estrogen receptors human subject interleukin 6 longitudinal human study nutrition of aging nutrition related tag osteoporosis pathologic bone resorption phosphorus questionnaires silicon tomography transforming growth factors
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
030832075
UEI
WS29EMGEVEJ4
Project Start Date
30-September-1991
Project End Date
31-May-2007
Budget Start Date
01-June-2003
Budget End Date
31-May-2004
Project Funding Information for 2003
Total Funding
$543,886
Direct Costs
$435,783
Indirect Costs
$108,103
Year
Funding IC
FY Total Cost by IC
2003
National Institute on Aging
$250,000
2003
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$293,886
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AR041398-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AR041398-12
Patents
No Patents information available for 5R01AR041398-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AR041398-12
Clinical Studies
No Clinical Studies information available for 5R01AR041398-12
News and More
Related News Releases
No news release information available for 5R01AR041398-12
History
No Historical information available for 5R01AR041398-12
Similar Projects
No Similar Projects information available for 5R01AR041398-12